Expanding Immunotherapy in Early-Stage HR+ and TNBC
Medscape,
Hope S. Rugo, MD, FASCO Immunotherapy has emerged as a key treatment approach for several solid tumors.
Hope S. Rugo, MD, FASCO Immunotherapy has emerged as a key treatment approach for several solid tumors.
New research suggests that, among patients with HER2-negative breast cancer, estrogen receptor (ER)-low and ER-negative tumors…